The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Jan. 08, 2016
Applicants:

The University of Tokyo, Tokyo, JP;

Chiba Prefecture, Chiba, JP;

Inventors:

Yuya Terashima, Tokyo, JP;

Kouji Matsushima, Tokyo, JP;

Etsuko Toda, Tokyo, JP;

Mikiya Otsuji, Tokyo, JP;

Meiji Itakura, Chiba, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); C12Q 1/04 (2006.01); G01N 33/53 (2006.01); C12Q 1/6883 (2018.01); G01N 33/68 (2006.01); G01N 33/574 (2006.01); C12Q 1/02 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12Q 1/025 (2013.01); C12Q 1/04 (2013.01); C12Q 1/6883 (2013.01); G01N 33/53 (2013.01); G01N 33/57492 (2013.01); G01N 33/6863 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/7158 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7095 (2013.01);
Abstract

Novel means that enables prediction of prognosis of a patient with cancer or inflammatory disease is disclosed. In the method for prediction of prognosis of a patient with cancer or inflammatory disease according to the present invention, the expression level of the FROUNT gene in a sample collected from the patient is measured. Since FROUNT is a poor prognostic factor, the lower the expression level of the FROUNT gene is, the better the prognosis in the patient is predicted to be. Or, the expression level of the CC chemokine receptor/ligand gene in a sample collected from the patient is measured. Since the CC chemokine receptor/ligand gene such as CCR2 or CCR5 is a good prognostic factor, the higher the expression level of the CC chemokine receptor/ligand gene is, the better the prognosis in the patient is predicted to be.


Find Patent Forward Citations

Loading…